Tabula Rasa HealthCare In... (TRHC)
Tabula Rasa HealthCare Statistics
Share Statistics
Tabula Rasa HealthCare has 27.05M shares outstanding. The number of shares has increased by 0% in one year.
| Shares Outstanding | 27.05M |
| Shares Change (YoY) | 0% |
| Shares Change (QoQ) | 0% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 17.87M |
| Failed to Deliver (FTD) Shares | 11.45K |
| FTD / Avg. Volume | 2.55% |
Short Selling Information
| Short Interest | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Valuation Ratios
The PE ratio is -1.55 and the forward PE ratio is null. Tabula Rasa HealthCare's PEG ratio is 0.25.
| PE Ratio | -1.55 |
| Forward PE | n/a |
| PS Ratio | 0.4 |
| Forward PS | null |
| PB Ratio | -2.11 |
| P/FCF Ratio | -5.62 |
| PEG Ratio | 0.25 |
Enterprise Valuation
Tabula Rasa HealthCare has an Enterprise Value (EV) of 386.36M.
| EV / Sales | 1.29 |
| EV / EBITDA | -15.68 |
| EV / EBIT | 52.52 |
| EV / FCF | -18.07 |
Financial Position
The company has a current ratio of 1.67, with a Debt / Equity ratio of -4.34.
| Current Ratio | 1.67 |
| Quick Ratio | 1.6 |
| Debt / Equity | -4.34 |
| Debt / EBITDA | -13.64 |
| Debt / FCF | -15.72 |
| Interest Coverage | -6.24 |
Financial Efficiency
Return on Equity is 135.6% and Return on Invested Capital is -29.73%.
| Return on Equity | 135.6% |
| Return on Assets | -20.13% |
| Return on Invested Capital | -29.73% |
| Revenue Per Employee | $291.64K |
| Profits Per Employee | $-75.3K |
| Employee Count | 1,027 |
| Asset Turnover | 0.78 |
| Inventory Turnover | 35.43 |
Taxes
| Income Tax | 389K |
| Effective Tax Rate | -0.51% |
Stock Price Statistics
The stock price has increased by 0% in the last 52 weeks. The beta is 1.58, so Tabula Rasa HealthCare's price volatility has been higher than the market average.
| Beta | 1.58 |
| 52-Week Price Change | 0% |
| 50-Day Moving Average | 10.36 |
| 200-Day Moving Average | 7.66 |
| Relative Strength Index (RSI) | 75.14 |
| Average Volume (20 Days) | 449.19K |
Income Statement
In the last 12 months, Tabula Rasa HealthCare had revenue of 299.52M and earned -77.33M in profits. Earnings per share was -3.18.
| Revenue | 299.52M |
| Gross Profit | 66.91M |
| Operating Income | -56.38M |
| Net Income | -77.33M |
| EBITDA | -24.64M |
| EBIT | -58.88M |
| Earnings Per Share (EPS) | -3.18 |
Balance Sheet
The company has 70.02M in cash and 336.13M in debt, giving a net cash position of -266.11M.
| Cash & Cash Equivalents | 70.02M |
| Total Debt | 336.13M |
| Net Cash | -266.11M |
| Retained Earnings | -407.86M |
| Total Assets | 355.94M |
| Working Capital | 52.99M |
Cash Flow
In the last 12 months, operating cash flow was 7.36M and capital expenditures -28.74M, giving a free cash flow of -21.38M.
| Operating Cash Flow | 7.36M |
| Capital Expenditures | -28.74M |
| Free Cash Flow | -21.38M |
| FCF Per Share | -0.88 |
Margins
Gross margin is 22.34%, with operating and profit margins of -18.82% and -25.82%.
| Gross Margin | 22.34% |
| Operating Margin | -18.82% |
| Pretax Margin | -25.69% |
| Profit Margin | -25.82% |
| EBITDA Margin | -8.23% |
| EBIT Margin | -18.82% |
| FCF Margin | -7.14% |
Dividends & Yields
TRHC does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | -64.31% |
| FCF Yield | -17.78% |
Analyst Forecast
Currently there are no analyst rating for TRHC.
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
Scores
| Altman Z-Score | -0.64 |
| Piotroski F-Score | 3 |